Say Hello!
Don’t be shy.

   

News

The national Medilink UK Healthcare Business Awards 2021 shortlist has been revealed, with some of the most innovative life sciences organisations in UK making the final list. The awards look back over the last 12 months and provide a platform for life science organisations to...

Glasgow, UK, 21 September 2021 – Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the appointment of Joshua T. Brumm as its new Independent Chairman, succeeding Satish Jindal. Amphista’s CEO Dr Nicola Thompson said, “On behalf of the Amphista team I...

Nottingham based contract research organisation (CRO) Cellomatics Biosciences has reported year-on-year organic revenue growth of 30 percent since its inception in 2015, as demand for its bespoke preclinical and early discovery phase laboratory services and expertise continues to soar. Based at BioCity Nottingham, Cellomatics is a...

Lanarkshire-based biotechnology company ILC Therapeutics has completed a £3.5m pre-IPO funding round.   Investors include Los Angeles-based lawyer and investor Robert Kopple; St Andrews-based Eos Angel Investment Syndicate; Scottish Enterprise; and members of ILCT's management. Kopple, along with St Andrews University Professor David Harrison and Association of the...

Investors include Mercia Asset Management and BGF Funding to further advance Locate Bio’s regenerative medicine pipeline of orthobiologics Locate Bio, an orthobiologics focused regenerative medicine company, is pleased to announce that it has raised an oversubscribed £10 million of equity investment in a funding round co-led by...

BioCity Nottingham-based Sygnature Discovery Ltd has entered a collaboration with Epigeneron Inc., a leading Japanese bio-venture company that uses a unique cutting-edge technology to identify potential drug targets that regulate the expression of disease-related genes. The two companies have signed a multi-project collaboration agreement to develop...